StonvexLoading…
StonvexStonvexStonvexCore line items from BX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.62B | $14.45B | $10.09B | $7.00B |
Operating Income | $1.46B | $7.17B | $4.81B | $3.37B |
Net Income | $649.73M | $3.02B | $2.00B | $1.38B |
EPS (Diluted) | $0.83 | $3.87 | $2.57 | $1.77 |
Total Assets | $48.33B | $47.71B | $46.55B | $45.37B |
Total Liabilities | $26.91B | $25.83B | $25.19B | $24.29B |
Cash & Equivalents | $2.45B | $2.63B | $2.43B | $2.24B |
Free Cash Flow OCF − CapEx | $957.64M | $4.55B | $3.50B | $1.93B |
Shares Outstanding | 751.54M | 748.69M | 747.81M | 739.06M |